Trimodal Therapy Plus Atezolizumab in Muscle-invasive Bladder Cancer
NCT03620435
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Safety Issues
Interventions
DRUG:
Atezolizumab
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre